Medullary Cancer of Breast with Atypical Features – A Case Study

A 58-year-old postmenopausal woman presented with swelling and redness of left breast for 9 months. The swelling gradually increased in size and was associated with yellow discharge from the nipple. History of mastalgia was present. There was no associated fever or weight loss. She denied any other ailment or family history of breast disease. She was multiparous but did not breastfeed her children. She was not sure about age at menarche and menopause was at the age of 55 years. On physical examination, skin of the left breast showed a peau d’orange appearance. The nipple was retracted. A lump was palpable beneath the areola. The lump was firm and irregular. It measured about 6.0 x 5.0 cm. A lymph node was palpable in the left axilla. Mammography showed multiple asymmetric densities involving most of the left breast. The margins were ill-defined. The overlying skin was thickened. The nipple was retracted. There was no evidence of micro or macro calcification. There was an enlarged lymph node in the left axilla (not shown). Ultrasonography of breast revealed thickened edematous skin and subcutaneous tissue of whole of the left breast. Multiple non-compressible hypoechoic lesions with irregular margins and posterior acoustic enhancements were present in all quadrants of the left breast. The largest one in the upper quadrant measured 2.7 x 1.6 cm. A large lymph node in the left axilla measuring 4.7 x 2.6 cm was noted. On Doppler color mapping, increased vascularity was noted. The lymph node showed thickened cortex and convex hilum. A CT scan of the chest, abdomen and pelvis with contrast was performed. It revealed irregular soft tissue density mass in the left breast measuring 7.5 x 6.8 x 3.8 cm, with ipsilateral lymph node enlargement in the axilla. There was no evidence of local or distant metastasis either in the chest, abdomen or pelvis. On the basis of the above findings, the lesion in the left breast was placed in BI-RADS category 5. The carcinoembryogenic antigen was 51.6ng/ml (normal range < 2.5ng/ml) and cancer antigen 15-3 (CA 15-3) was 7.7 (reference range < 31U/ml). Fine needle aspiration revealed malignant sheet of cells containing bizarre nucleoli with chronic inflammatory cells. The patient underwent modified radical mastectomy with axillary clearance. Gross appearance of the breast specimen revealed a large firm mass 8 x 7 x 4 cm, gray in color with white areas. Microscopic picture revealed breast fibrous tissue stroma that was invaded by large sheets of pleomorphic malignant ductal cells. The tumor cells were not forming glands but formed sheets so that clear boundaries between cells could not be seen. Diffuse areas of necrosis and chronic inflammation were also present. Sections of nipple and areola revealed focal ulcers with superficial spread in near keratinous layers. Out of the 10 axillary lymph nodes which were dissected, 4 showed metastasis. Immunohistochemistry showed that the mass was estrogen receptor (ER) and progesterone receptor (PR) negative, while HER2 and E-cadherin were positive.

According to the World Health Organization, over 1.2 million women are diagnosed with breast cancer annually worldwide.(1) Infiltrating ductal carcinoma is a broad entity which comprises of tumors that exhibit one or more characteristics of specific types of breast cancers. There is evidence of tubular, papillary, medullary or mucinous differentiation microscopically.(2) The etiology is still unknown. Marcus et al have suggested that BRCA1-associated tumors were more likely to be of medullary or atypical medullary type.(3) For the diagnosis of medullary carcinoma to be made, strict histopathologic criteria should be completed. Traditionally, there has been no clear consensus among pathologists of the best diagnostic parameters for classifying medullary carcinoma. Since the histopathological grouping of breast cancer is subjective, this results in high interobserver variability.(4) Ridolfi and his colleagues set up criteria for the diagnosis of medullary carcinoma in 1977 which included presence of five elements, namely syncytial growth pattern in at least 75% of the areas examined, microscopic circumscription, high nuclear grade, lymphoplasmacytic infiltrate and absence of tubular differentiation and/or an intraductal component.(2,5) Here it is worth noting that a cancer can be termed as classic medullary only if all of the five features mentioned above are present. “Atypical” medullary carcinoma is a term often used if one or two of the above mentioned features are absent, whereas if there is poor correspondence within the five categories, then the term ‘ductal carcinoma’ not otherwise specified (NOS) is applied.